Optimising RT dose for anal cancer - the development of three clinical trials in one platform
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Elsevier
2017
|
_version_ | 1797063292729950208 |
---|---|
author | Sebag-Montefiore, D Adams, R Bell, S Berkman, L Gilbert, D Glynne-Joones, R Goh, V Gregory, W Harrison, M Kachnic, L Lee, M McParland, L Muirhead, R O'Neil, B Hutchins, G Rao, S Renehan, A Smith, A Velikova, G Hawkins, M |
author_facet | Sebag-Montefiore, D Adams, R Bell, S Berkman, L Gilbert, D Glynne-Joones, R Goh, V Gregory, W Harrison, M Kachnic, L Lee, M McParland, L Muirhead, R O'Neil, B Hutchins, G Rao, S Renehan, A Smith, A Velikova, G Hawkins, M |
author_sort | Sebag-Montefiore, D |
collection | OXFORD |
description | |
first_indexed | 2024-03-06T20:57:45Z |
format | Conference item |
id | oxford-uuid:39d74933-7319-47b8-b14f-c88bef2683f2 |
institution | University of Oxford |
last_indexed | 2024-03-06T20:57:45Z |
publishDate | 2017 |
publisher | Elsevier |
record_format | dspace |
spelling | oxford-uuid:39d74933-7319-47b8-b14f-c88bef2683f22022-03-26T13:57:56ZOptimising RT dose for anal cancer - the development of three clinical trials in one platformConference itemhttp://purl.org/coar/resource_type/c_5794uuid:39d74933-7319-47b8-b14f-c88bef2683f2Symplectic Elements at OxfordElsevier2017Sebag-Montefiore, DAdams, RBell, SBerkman, LGilbert, DGlynne-Joones, RGoh, VGregory, WHarrison, MKachnic, LLee, MMcParland, LMuirhead, RO'Neil, BHutchins, GRao, SRenehan, ASmith, AVelikova, GHawkins, M |
spellingShingle | Sebag-Montefiore, D Adams, R Bell, S Berkman, L Gilbert, D Glynne-Joones, R Goh, V Gregory, W Harrison, M Kachnic, L Lee, M McParland, L Muirhead, R O'Neil, B Hutchins, G Rao, S Renehan, A Smith, A Velikova, G Hawkins, M Optimising RT dose for anal cancer - the development of three clinical trials in one platform |
title | Optimising RT dose for anal cancer - the development of three clinical trials in one platform |
title_full | Optimising RT dose for anal cancer - the development of three clinical trials in one platform |
title_fullStr | Optimising RT dose for anal cancer - the development of three clinical trials in one platform |
title_full_unstemmed | Optimising RT dose for anal cancer - the development of three clinical trials in one platform |
title_short | Optimising RT dose for anal cancer - the development of three clinical trials in one platform |
title_sort | optimising rt dose for anal cancer the development of three clinical trials in one platform |
work_keys_str_mv | AT sebagmontefiored optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT adamsr optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT bells optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT berkmanl optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT gilbertd optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT glynnejoonesr optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT gohv optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT gregoryw optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT harrisonm optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT kachnicl optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT leem optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT mcparlandl optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT muirheadr optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT oneilb optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT hutchinsg optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT raos optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT renehana optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT smitha optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT velikovag optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform AT hawkinsm optimisingrtdoseforanalcancerthedevelopmentofthreeclinicaltrialsinoneplatform |